IHM, M., FF, R., K, A., J, B., C, v. B., S, J., . . . M, J. (2026). Elexacaftor/tezacaftor/ivacaftor is safe and effectively reduces sino-nasal symptoms in people with cystic fibrosis post lung transplantation. Respiratory medicine, 257, 108807. https://doi.org/10.1016/j.rmed.2026.108807
Παραπομπή σε μορφή Chicago (17η εκδ.)IHM, Mathiesen, et al. "Elexacaftor/tezacaftor/ivacaftor Is Safe and Effectively Reduces Sino-nasal Symptoms in People with Cystic Fibrosis Post Lung Transplantation." Respiratory Medicine 257 (2026): 108807. https://doi.org/10.1016/j.rmed.2026.108807.
Παραπομπή σε μορφή MLA (9th εκδ.)IHM, Mathiesen, et al. "Elexacaftor/tezacaftor/ivacaftor Is Safe and Effectively Reduces Sino-nasal Symptoms in People with Cystic Fibrosis Post Lung Transplantation." Respiratory Medicine, vol. 257, 2026, p. 108807, https://doi.org/10.1016/j.rmed.2026.108807.